Argentina announces COVID-19 vaccine supply deal with Moderna

Reuters2021-07-09

By Agustin Geist

July 8 (Reuters) - Argentina on Thursday announced it will sign a COVID-19 vaccine supply agreement with Moderna , as the country attempts to speed up the inoculation of its population and sidestep a possible third wave of the coronavirus.

Cabinet chief Santiago Cafiero told Argentina's Congress that a deal would be signed with U.S.-based Moderna on Monday, but did not detail the number of doses being bought or the agreed delivery dates.

Argentina has so far largely built its COVID-19 inoculation program around Russia's Sputnik V vaccine, China's Sinopharm

vaccine and British-Swedish firm AstraZeneca's vaccine. It has vaccinated 23.7 million of its 45 million inhabitants with at least one dose of a COVID-19 vaccine, and 4.9 million people have received two.

As of Wednesday, Argeninta had registered 4.6 million cases of COVID-19 and 97,000 related deaths. The country is at present seeing a decline in cases after a precipitous second wave that triggered fresh lockdowns.

(Reporting by Agustin Geist Editing by Nicolas Misculin and Paul Simao)

((nicolas.misculin@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1